
  <style>
  .gh-table table { 
    border-collapse: collapse; 
    width: 100%;
    border: 1px solid #444;
    font-size: 12px;
  }
  .gh-table th, .gh-table td { 
    border: 1px solid #444; 
    padding: 4px 6px; 
    vertical-align: top;
    font-weight: 400 !important;   /* regular font */
  }
  .gh-table th { 
    .gh-table th { background: #f5f5f5; text-align: left; }
  }
  .gh-table th { font-weight: 700 !important; }
    @media print {
      .gh-table { font-size: 10px; }
    }
  </style>
  <div class='gh-table'><table><thead><tr><th>record_id</th><th>visit</th><th>Molecola (1)</th><th>Molecola (2)</th><th>description</th></tr></thead><tbody><tr><td>LS15</td><td>1</td><td>Alendronic acid</td><td>Acetylsalicylic acid</td><td>The risk or severity of adverse effects can be increased when Acetylsalicylic
acid is combined with Alendronic acid.</td></tr><tr><td>LS15</td><td>1</td><td>Alendronic acid</td><td>Furosemide</td><td>The risk or severity of hypocalcemia can be increased when Furosemide is
combined with Alendronic acid.</td></tr><tr><td>LS15</td><td>1</td><td>Alendronic acid</td><td>Lansoprazole</td><td>The therapeutic efficacy of Alendronic acid can be decreased when used in
combination with Lansoprazole.</td></tr><tr><td>LS15</td><td>1</td><td>Dutasteride</td><td>Acetylsalicylic acid</td><td>The risk or severity of hypertension can be increased when Acetylsalicylic acid
is combined with Dutasteride.</td></tr><tr><td>LS15</td><td>1</td><td>Furosemide</td><td>Acetylsalicylic acid</td><td>The risk or severity of increased serum creatinine can be increased when
Acetylsalicylic acid is combined with Furosemide.</td></tr><tr><td>LS15</td><td>1</td><td>Furosemide</td><td>Dutasteride</td><td>Dutasteride may decrease the antihypertensive activities of Furosemide.</td></tr><tr><td>LS15</td><td>1</td><td>Furosemide</td><td>Folic acid</td><td>Furosemide may decrease the excretion rate of Folic acid which could result in a
higher serum level.</td></tr><tr><td>LS15</td><td>1</td><td>Furosemide</td><td>Insulin human</td><td>The risk or severity of hypoglycemia can be increased when Furosemide is
combined with Insulin human.</td></tr><tr><td>LS15</td><td>1</td><td>Insulin human</td><td>Acetylsalicylic acid</td><td>The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid
is combined with Insulin human.</td></tr><tr><td>LS15</td><td>1</td><td>Lamivudine</td><td>Acetylsalicylic acid</td><td>Acetylsalicylic acid may decrease the excretion rate of Lamivudine which could
result in a higher serum level.</td></tr><tr><td>LS15</td><td>1</td><td>Lamivudine</td><td>Alendronic acid</td><td>The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be
increased when Alendronic acid is combined with Lamivudine.</td></tr><tr><td>LS15</td><td>1</td><td>Lamivudine</td><td>Folic acid</td><td>Folic acid may decrease the excretion rate of Lamivudine which could result in a
higher serum level.</td></tr><tr><td>LS15</td><td>1</td><td>Lamivudine</td><td>Furosemide</td><td>Furosemide may decrease the excretion rate of Lamivudine which could result in a
higher serum level.</td></tr><tr><td>LS15</td><td>1</td><td>Lamivudine</td><td>Lansoprazole</td><td>Lansoprazole may decrease the excretion rate of Lamivudine which could result in
a higher serum level.</td></tr><tr><td>LS15</td><td>1</td><td>Lansoprazole</td><td>Acetylsalicylic acid</td><td>The metabolism of Acetylsalicylic acid can be decreased when combined with
Lansoprazole.</td></tr><tr><td>LS15</td><td>1</td><td>Lansoprazole</td><td>Dolutegravir</td><td>Lansoprazole may decrease the excretion rate of Dolutegravir which could result
in a higher serum level.</td></tr><tr><td>LS15</td><td>1</td><td>Lansoprazole</td><td>Ezetimibe</td><td>Lansoprazole may decrease the excretion rate of Ezetimibe which could result in
a higher serum level.</td></tr><tr><td>LS15</td><td>1</td><td>Lansoprazole</td><td>Folic acid</td><td>Lansoprazole may decrease the excretion rate of Folic acid which could result in
a higher serum level.</td></tr><tr><td>LS15</td><td>1</td><td>Silodosin</td><td>Dolutegravir</td><td>The serum concentration of Dolutegravir can be increased when it is combined
with Silodosin.</td></tr><tr><td>LS15</td><td>1</td><td>Silodosin</td><td>Furosemide</td><td>The risk or severity of orthostatic hypotension and dizziness can be increased
when Furosemide is combined with Silodosin.</td></tr><tr><td>LS15</td><td>1</td><td>Trazodone</td><td>Acetylsalicylic acid</td><td>The risk or severity of gastrointestinal bleeding can be increased when
Trazodone is combined with Acetylsalicylic acid.</td></tr><tr><td>LS15</td><td>1</td><td>Trazodone</td><td>Cholecalciferol</td><td>The metabolism of Trazodone can be decreased when combined with Cholecalciferol.</td></tr><tr><td>LS15</td><td>1</td><td>Trazodone</td><td>Dutasteride</td><td>The risk or severity of hypertension can be increased when Trazodone is combined
with Dutasteride.</td></tr><tr><td>LS15</td><td>1</td><td>Trazodone</td><td>Furosemide</td><td>Trazodone may decrease the antihypertensive activities of Furosemide.</td></tr><tr><td>LS15</td><td>1</td><td>Trazodone</td><td>Lansoprazole</td><td>The metabolism of Trazodone can be decreased when combined with Lansoprazole.</td></tr><tr><td>LS15</td><td>1</td><td>Trazodone</td><td>Silodosin</td><td>Trazodone may increase the orthostatic hypotensive, hypotensive, and
antihypertensive activities of Silodosin.</td></tr></tbody></table></div>
